相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression
Fieke Lamers et al.
EUROPEAN JOURNAL OF CANCER (2012)
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
E. E. Santo et al.
ONCOGENE (2012)
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe
Fieke Lamers et al.
ENDOCRINE-RELATED CANCER (2011)
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D. Lewis et al.
INVESTIGATIONAL NEW DRUGS (2011)
Comparative Proteomics of Colon Cancer Stem Cells and Differentiated Tumor Cells Identifies BIRC6 as a Potential Therapeutic Target
WJ Van Houdt et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication
Maija Wolf et al.
BMC CANCER (2010)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Sara De Brouwer et al.
CLINICAL CANCER RESEARCH (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Molecular pathogenesis of peripheral neuroblastic tumors
I. Janoueix-Lerosey et al.
ONCOGENE (2010)
Use of Human Cancer Cell Lines Mitochondria to Explore the Mechanisms of BH3 Peptides and ABT-737-Induced Mitochondrial Membrane Permeabilization
Nelly Buron et al.
PLOS ONE (2010)
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
Brian J. Lestini et al.
CANCER BIOLOGY & THERAPY (2009)
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh et al.
CLINICAL CANCER RESEARCH (2009)
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
Tom Van Maerken et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma
Saloua Toujani et al.
PLOS ONE (2009)
Down-regulation of caspase-2 by rottlerin via protein kinase c-δ-independent pathway
Alakananda Basu et al.
CANCER RESEARCH (2008)
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma
Jan J. Molenaar et al.
CANCER RESEARCH (2008)
Final stages of cytokinesis and midbody ring formation are controlled by BRUCE
Christian Pohl et al.
CELL (2008)
Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
Anne Fix et al.
GENES CHROMOSOMES & CANCER (2008)
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
J. Shen et al.
ONCOGENE (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
Regulation of mitochondrial Smac/DIABLO-selective release by survivin
G. Ceballos-Cancino et al.
ONCOGENE (2007)
Overexpression of apollon, an antiapoptotic protein, is associated with poor prognosis in childhood De novo acute myeloid leukemia
Ki Woong Sung et al.
CLINICAL CANCER RESEARCH (2007)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events
J. Yu et al.
ONCOGENE (2007)
Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2
LK Nutt et al.
CELL (2005)
The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development
JY Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9
XB Qiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pediatric neuroblastomas: genetic and epigenetic 'Danse Macabre'
MM van Noesel et al.
GENE (2004)
Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function
YY Hao et al.
NATURE CELL BIOLOGY (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN
T Teitz et al.
ONCOGENE (2002)
DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9
PG Ekert et al.
JOURNAL OF CELL BIOLOGY (2001)
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
CY Du et al.
CELL (2000)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
分享论文
